Skip to content
Scailyte
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
Scailyte
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • ScaiVision
  • Services
    • Cell & Gene Therapy
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch

Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection (Cell Reports Medicine)

In this study, exploiting ScaiVision’s unique sensitivity, we were able to identify an immune population strongly linked to the development of complications from COVID associated with a high mortality rate.

Continue reading
publication

Sensitive detection of rare disease-associated cell subsets via representation learning (Nature Communications)

Original manuscript establishing the framework which laid the groundwork for our biomarker discovery platform ScaiVision. Initially designed for CyTOF data, we have now extended this framework for the integrative analysis of a large variety of data modalities enabling true multimodal analyses crucial for precision medicine.

Continue reading
publication
Scailyte

Contact Information:

Scailyte AG
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C


USA Contact Information:
Scailyte AG
c/o swissnex Boston
420 Broadway,
Cambridge, MA 02138,
USA

Get in touch

  • Careers
  • Contact us
  • Home
  • Publications
  • News
  • About us
  • ScaiVision
  • Cell & Gene Therapy
  • Immunology & Oncology
  • Discovery Pipeline
Scailyte
Contact Information:

Scailyte AG
WSJ-500.1.101
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C
  • Clinical IVD Pipeline
  • ScaiVision
  • Partnering
  • Home
  • About
  • News
  • Careers
  • Contact us

Scailyte 2021 © All rights reserved. Scailyte, ScaiVision and the Scailyte logo are registered trademarks.

Terms & Conditions
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website you agree to our policies.AcceptTerms & Conditions